News
BRCTF
18.48
NaN%
--
Biogen/ Eisai win EU approval for Alzheimer’s therapy
Seeking Alpha · 4d ago
Weekly Report: what happened at BRCTF last week (0407-0411)?
Weekly Report · 5d ago
Weekly Report: what happened at BRCTF last week (0331-0404)?
Weekly Report · 04/07 11:06
Weekly Report: what happened at BRCTF last week (0324-0328)?
Weekly Report · 03/31 11:17
Weekly Report: what happened at BRCTF last week (0317-0321)?
Weekly Report · 03/24 11:05
Weekly Report: what happened at BRCTF last week (0310-0314)?
Weekly Report · 03/17 11:15
Weekly Report: what happened at BRCTF last week (0303-0307)?
Weekly Report · 03/10 11:17
Weekly Report: what happened at BRCTF last week (0224-0228)?
Weekly Report · 03/03 11:16
Biogen, Eisai Alzheimer’s drug sent back for EU nod after safety review
Seeking Alpha · 02/28 14:06
BioArctic AB's Partner Eisai Says EU's CHMP Reaaffirms Positive Opinion For Lecanemab
NASDAQ · 02/28 13:46
Weekly Report: what happened at BRCTF last week (0217-0221)?
Weekly Report · 02/24 11:16
BioArctic And Bristol Myers Squibb Finalize $100M Licensing Deal For PyroGlu-Aβ Antibody Program After U.S. Antitrust Clearance
Benzinga · 02/20 06:44
Weekly Report: what happened at BRCTF last week (0210-0214)?
Weekly Report · 02/17 11:14
Weekly Report: what happened at BRCTF last week (0203-0207)?
Weekly Report · 02/10 11:08
Weekly Report: what happened at BRCTF last week (0127-0131)?
Weekly Report · 02/03 11:12
Weekly Report: what happened at BRCTF last week (0120-0124)?
Weekly Report · 01/27 11:15
Weekly Report: what happened at BRCTF last week (0113-0117)?
Weekly Report · 01/20 11:07
Weekly Report: what happened at BRCTF last week (0106-0110)?
Weekly Report · 01/13 11:08
Weekly Report: what happened at BRCTF last week (1230-0103)?
Weekly Report · 01/06 11:15
Weekly Report: what happened at BRCTF last week (1223-1227)?
Weekly Report · 12/30/2024 11:10
More
Webull provides a variety of real-time BRCTF stock news. You can receive the latest news about BioArctic AB through multiple platforms. This information may help you make smarter investment decisions.
About BRCTF
BioArctic AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of treatments, which aim at diseases that affect the central nervous system (CNS). Its therapeutic areas encompass neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, complete spinal cord injury, as well as other CNS disorders. The Company owns a technology platform, which develops a range of therapeutic monoclonal antibodies. The Company's pipeline includes product candidates in various clinical phases, such as BAN2401, AE1501, BAN0805, imaging and biochemical biomarkers, BBB-technology and SC0806. The Company also operates through SpineMedical AB.